The World Health Organization (WHO) Essential Medicines List (EML) informs policy makers about which medications should be prioritized and is particularly important for countries with limited resources. However, the EML lacks vital medicines used in paediatric rheumatology, the inclusion of which could transform the lives of many children around the world.

中文翻译：

---

更新WHO EML，以改善全球儿科风湿病学。

世界卫生组织（WHO）基本药物清单（EML）告知决策者应优先考虑哪些药物，这对于资源有限的国家尤其重要。但是，EML缺乏用于儿科风湿病学的重要药物，将其包括在内可能会改变世界上许多儿童的生活。